leisure time -WSS

leisure time

author：fashion 2025-09-27 09:59:02 - browse：5448

AbbVie announced Tuesday that CEO Richard Gonzalez, who has managed the company’s ascent since it was spun off from the device maker Abbott Laboratories in 2013, will step down in July. Gonzalez had previously said he would depart when AbbVie had a plan in place to move on from its best-selling drug, Humira, which is now facing competition from cheaper biosimilars.

He will be replaced by Chief Operating Officer Robert Michael, who, like Gonzalez, is a longtime AbbVie executive. Gonzalez, 70, will become executive chairman of the board of directors.

Gonzalez should be a sobering reminder to the drug industry’s critics of how resilient a CEO’s reputation can be. Because while he has been a subject of nearly constant criticism for AbbVie’s handling of Humira and the patents protecting it, investors are likely to remember him fondly.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： Lung cancer is America's deadliest cancer. Yet so few get screened

explore

WSS

Doctor of U.S. President Joe Biden says he is fit for duty

New details revealed about Purdue's marketing of OxyContin

Virtual repurposing can help discover new uses for existing drugs

Cancer drug shortages' outsize impact on ovarian cancer patients

NEJM study measures Covid brain fog, impact on IQ

Hilary may become 1st tropical storm to make landfall in California in 84 years

leisure time

leisure time

focus

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Childhood vaccination ad campaign launches in the U.K.

As demand for Covid shots wanes, Moderna seeks its next success

Doctor of U.S. President Joe Biden says he is fit for duty

Supreme Court strikes down use of affirmative action

Redefining sustainability for the pharmaceutical industry

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Trump cancels press conference intended to dispute Georgia election interference charges

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Readout Newsletter: Beam, Prozac, "TechBio" and more

explore

Readout Newsletter: GSK, Viking Therapeutics, mifepristone news

There should be a 'Moonshot' or 'Warp Speed' for rare diseases

Elisabeth Bik tackles the widespread issue of research misconduct

Beware the threat of staffing cuts at the CDC

Special counsel raises new conflict of interest concerns for De Oliveira's lawyer

Majority of Americans think Trump's Ga. election interference case is serious: POLL

focus

explore

explore

entertainment